Comparable anal HPV burden and abnormal cytology in MSM using PrEP and MSM living with HIV: implications for screening and prevention
MSM using PrEP showed a burden of HR-HPV infection and abnormal anal cytology comparable to that observed in MSM living with HIV. These findings suggest that MSM-PrEP constitutes a high-risk group that may warrant reconsideration of current anal cancer screening strategies. The potential protective effect of postsexual-debut HPV vaccination merits further investigation.
Authors
- Michel Verheyden (ORCID: https://orcid.org/0000-0002-1232-1376)
- Jan Gutermuth (ORCID: https://orcid.org/0000-0002-9252-6004)
- Marc Goossens
- Sébastien Kindt (ORCID: https://orcid.org/0000-0002-4282-4230)
- Shaira Sahebali (ORCID: https://orcid.org/0000-0002-5450-4381)
- Sabine Allard
- Yora Mostmans (ORCID: https://orcid.org/0000-0002-1266-9524)
- Jason Brunetta (ORCID: https://orcid.org/0000-0002-0506-8616)
- Magali Surmont
Institutions
- Université Libre de Bruxelles (BE)
- Vrije Universiteit Brussel (BE)
- Universitair Ziekenhuis Brussel (BE)
- Maple Leaf Medical Clinic (CA)
- Mathys (Netherlands) (NL)
Publication Details
- Journal
- Sexually Transmitted Infections
- Published
- 2026-03-27
- DOI
- https://doi.org/10.1136/sextrans-2025-056634
- Primary Topic
- Cervical Cancer and HPV Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00